Will PSMA-targeting diagnostics and therapeutics revolutionize Prostate Cancer care?
29 January 2020
PSMA-based imaging is poised to be widely adopted as standard imaging practice in prostate cancerRead more
Can Digital Health Fundamentally Change Healthcare in APAC?
17 January 2020
With high levels of investment in technology to tackle some of APAC's biggest healthcare challenges, digital health companies are poised to redefine the region's healthcare.Read more
Rapid Approvals & Innovative Approaches, But Which Sickle Cell Therapies Will Offer Real Benefits?
28 November 2019
Recent, expedited FDA approvals of Novartis’ Adakveo and GBT’s Oxbryta, may for the first time enable patients with Sickle cell disease a choice of treatment options. Here we analyse these two new therapiesRead more